1
Total investments
1
Early stage
0
Mid stage
0
Late stage
9y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Executive Board Member
Mar 2017
iMetabolic Biopharma Corporation (iMBP) is an exciting early stage platform biopharma company that is developing First In Class therapeutics for the treatment of a number of diseases with high unmet medical need. Through the application of its proprietary iPlatform technology, iMBP has established itself as a Leader in TechBio, a nouveau field of drug discovery and development driven by technology innovation. Having already established a pipeline of five early stage therapeutic assets, with additional molecules already in design phase, iMBP is at the precipice in its next leg of evolution.
Based in Tempe, AZ; iMBP is growing its operations to support the development of both its platform technology and therapeutic pipeline. iMBP is now strategically poised to become a disruptive force in the biopharma industry and is poised to move forward ground breaking science to help improve patient care.
https://l.instagram.com/?u=https%3A%2F%2Flinktr.ee%2Fdr_urban_a_kiernan&e=AT1Hx7OAnm1Esgp1qPUsti_FJonAgqb7-BwI4lYRA9yTEVPRIqaN-v1miB74Ka5wcsiVCE1FOqkFLE20WA0uLkhLAuE9FDNspJfc3w
Experience · 3 entries
All (3)
Investments (1)
Founder (1)
Board (1)
2017
Executive Board Member
Mar 2017
iMetabolic Biopharma Corporation (iMBP) is an exciting early stage platform biopharma company that is developing First In Class therapeutics for the treatment of a number of diseases with high unmet medical need. Through the application of its proprietary iPlatform technology, iMBP has established itself as a Leader in TechBio, a nouveau field of drug discovery and development driven by technology innovation. Having already established a pipeline of five early stage therapeutic assets, with additional molecules already in design phase, iMBP is at the precipice in its next leg of evolution.
Based in Tempe, AZ; iMBP is growing its operations to support the development of both its platform technology and therapeutic pipeline. iMBP is now strategically poised to become a disruptive force in the biopharma industry and is poised to move forward ground breaking science to help improve patient care.
https://l.instagram.com/?u=https%3A%2F%2Flinktr.ee%2Fdr_urban_a_kiernan&e=AT1Hx7OAnm1Esgp1qPUsti_FJonAgqb7-BwI4lYRA9yTEVPRIqaN-v1miB74Ka5wcsiVCE1FOqkFLE20WA0uLkhLAuE9FDNspJfc3w
2010
Founder
Feb 2010
Our mission is quite simple…we are here to help your commercial organization be more strategic, productive, competent and most importantly successful.
“Customer Value” is NOT just a mantra to us…it’s our lively hood and if our clients aren’t happy we’re not happy. We chose to start this business because we saw a need that wasn’t being addressed and felt our years of experience could be the solution. AH2 Management is a firm that understands the commercial side of the business and wishes to impart that wisdom to its clients.
Our specific competencies: Global Commercial Operations, Corporate Strategy, Business Development, Private Equity/Venture Capital, Mergers and Acquisitions, Corporate Finance, Company Analysis, Global Marketing, Project Management, R&D Management, Pain Management, Pharmaceuticals, Biotechnology, Diagnostics, Medical Devices, Animal Healthcare/Agriculture, Chemicals, Training.
We also currently operate in the ventures investment space most of my time is spent working with businesses ranging from $50 million in profits to $1 billion+ in profits. Specific responsibilities have included developing innovative commercial infrastructure strategies:
· Global Strategic Business Diagnostics/Fundraising/Capital Investments
· Global Commercial/Channel Operations
· Private Equity/Venture Capital/Family Office
· Mergers & Acquisitions Negotiations
· Corporate Sales Facilitation
· Six Sigma Process Excellence
Senior Managing Director (Healthcare)
Feb 2010
Our mission is quite simple…we are here to help your commercial organization be more strategic, productive, competent and most importantly successful.
“Customer Value” is NOT just a mantra to us…it’s our lively hood and if our clients aren’t happy we’re not happy. We chose to start this business because we saw a need that wasn’t being addressed and felt our years of experience could be the solution. AH2 Management is a firm that understands the commercial side of the business and wishes to impart that wisdom to its clients.
Our specific competencies: Global Commercial Operations, Corporate Strategy, Business Development, Private Equity/Venture Capital, Mergers and Acquisitions, Corporate Finance, Company Analysis, Global Marketing, Project Management, R&D Management, Pain Management, Pharmaceuticals, Biotechnology, Diagnostics, Medical Devices, Animal Healthcare/Agriculture, Chemicals, Training.
We also currently operate in the ventures investment space most of my time is spent working with businesses ranging from $50 million in profits to $1 billion+ in profits. Specific responsibilities have included developing innovative commercial infrastructure strategies:
· Global Strategic Business Diagnostics/Fundraising/Capital Investments
· Global Commercial/Channel Operations
· Private Equity/Venture Capital/Family Office
· Mergers & Acquisitions Negotiations
· Corporate Sales Facilitation
· Six Sigma Process Excellence
Similar investors
Co-investors and Biotechnology early-stage investors in United States
Investor lists
Lists that match André's portfolio
- Biotechnology early-stage investors in United States2,072 investors
- Early-stage startup investors in United States3,677 investors




